WILLIAM TAYLOR: Open Payments
NPI 1164152401 · POCATELLO, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$414 in 22 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $242 · 2025 $414
Food & beverage: $414
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $87 |
| Organon LLC | 6 | $82 |
| UCB, Inc. | 4 | $71 |
| Incyte Corporation | 2 | $44 |
| Lilly USA, LLC | 1 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Amgen Inc. | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| Arcutis Biotherapeutics, Inc. | 1 | $19 |
| LEO Pharma Inc. | 1 | $16 |
Products named: SKYRIZI, Bimzelx, OPZELURA, OLUMIANT, VTAMA, DUPIXENT, OTEZLA, XOLAIR.
Industry payments across ID — which companies pay providers there.
